Many health care stocks outperform the market, OCGN is gaining 18%

On Monday, shares of Ocugen Inc (OCGN) rose 18.07 percent to $13.98 in what was an all-around good trading morning for the stock market. Ocugen Inc. finished $4.79 behind its 52-week high ($18.77), which it hit on February 8th.

What happened to the OCGN?

Investors in Ocugen (OCGN) have had a rocky ride this year, but those who were able to endure the volatility have reaped the benefits. While the stock has nearly doubled in the last month, the year-to-date performance indicates a 664 percent gain.

Ocugen's success has been founded on its seemingly impossible metamorphosis from a company focused on eye illnesses to one chasing the potential given by Covid-19; the biotech owns the US rights to Covaxin, a Covid-19 vaccine candidate developed by Bharat Biotech in India.

Biotech stock’s performance

  • Artelo Biosciencs (ARTL) moved upwards by 55.11% to $1.11.
  • Ocular Therapeutix Inc (OCUL) increased 6.63 percent to $7.08
  • Kodiak Sciences Inc (KOD) rose 7.59 percent to $125.98, outperforming some of its competitors. The trading volume (107.8 million) exceeded the 50-day average volume of 23.3 million.

Please share your opinion:

Which health care stocks could be the belles of the ball in November?

Do you recommend to buy Ocugen’s stock?

What do you think is the reason for the rise in ocugen's stock price?

Do you think Ocugen's COVID-19 vaccine will continue to drive its shares higher this month?

$Histogenics(OCGN)$ $Artelo Biosciences, Inc.(ARTL)$ $Ocular Therapeutix(OCUL)$ $Kodiak Sciences Inc.(KOD)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论13

  • 推荐
  • 最新
  • RoyRoberts
    ·2021-11-02
    精彩
    I recommend nothing!!! ONLY my opinion!!! Ladies and Gentleman, Remember: 1) The prime minister of India got Covaxin!!! 2) Millions of Indians got Covaxin!! 3) According to Google!! Corona in India went down dramatically!! GOOGLE IT!!! seems that Covaxin works:))) We face in the short term 3 stages: 1) WHO approval. 2) Canada approval. 3) FDA approval. I hold, just HOLD. GOOD LUCK:)
    回复
    举报
  • VincentHughes
    ·2021-11-02
    FEB 8 LOW 9.13 HIGH 18.77 CLOSED 9.13 VOL 719,489,088 MASSIVE. WHAT'S THE LIKELIHOOD, IF ANY , PPS GOES BEYOND $18MARK? WILL IT HAPPEN BEFORE OR AFTER APPROVAL? JUST S QUESTION NOTHING MORE DO YOUR OWN DD. INVEST AT YOUR OWN RISK. GLTA
    回复
    举报
  • HenryHoward
    ·2021-11-02
    Ocgn approval is 1000 %guaranteed because loads of countries already approved it and too many countries already put ocgn to approved vaccines list like Australia new Zealand and many others. Ocgn will own the future!!
    回复
    举报
  • BartonBecky
    ·2021-11-02
    我不认为疫苗的流行会推高其股价。我想恰恰相反,随着越来越多的人接种了疫苗,人们对它的需求不再那么迫切,你可以看到人们甚至不想戴口罩了!
    回复
    举报
  • MariaEvelina
    ·2021-11-02
    我更喜欢VTVT。我跟踪这家公司很长时间了。他们的业务规模一直在扩大,市盈率也一直维持在较高水平,那么你们的市盈率怎么样?你不能仅仅通过快速上升来分析它,对吧?😯
    回复
    举报
  • JudithGrant
    ·2021-11-02
    你真的找到了亮点,这家公司也很有远见,同时取得了转型的成功,我之前买了它,我觉得它还会继续涨,正在准备增持。
    回复
    举报
  • VictoriaArthur
    ·2021-11-02
    LOOKS LIKE MRNA DOWN AGAIN TODAY. IMHO, WOULD BE NICE IF SOME HOLDERS MIGRATES TO OCGN...THEYLL BE ADDITIONAL FUEL TO THE FIRE.
    回复
    举报
  • JackPowell
    ·2021-11-02
    Winter is coming again, and the mutant virus is more destructive, and the company has obviously made a successful transformation, so it must be held!😊
    回复
    举报
  • LesleyNewman
    ·2021-11-02
    我真的很推荐买Ocugen的股票,因为新型冠状病毒已经成为常态,疫苗也不是永久免疫人,所以还有很大的成长空间。所以如果你想长期投资,你可以买。
    回复
    举报
  • Tracccy
    ·2021-11-02
    Come on, the medical sector is coming to an end. If it goes up a lot, then it will fall a lot, and it's still the safest for technology companies.🙅
    回复
    举报
  • AgathaHume
    ·2021-11-02
    I support buying stocks, medical stock is still a hot choice, the rest I do not know, this I have been paying attention to, I strongly suggest!🤣
    回复
    举报
  • JulianAlerander
    ·2021-11-02
    I am also very optimistic about NVUS,ONCY, I think the medical sector will become a big hit, people can no longer ignore novel coronavirus. Cymbal🤧
    回复
    举报